SCHEMBL7273992

SCHEMBL7273992

CCCC(Br)C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.48
▸ DPP4 P27487 2/20 0.47
▸ RECQL P46063 1/20 0.46
▸ EPHX1 P07099 1/20 0.46
▸ GPR119 Q8TDV5 4/20 0.45
▸ USP2 O75604 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ MAPT P10636 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ NR1H2 P55055 1/20 0.42
▸ EED O75530 1/20 0.42
▸ RBBP4 Q09028 1/20 0.42
▸ SUZ12 Q15022 1/20 0.42
▸ EZH2 Q15910 1/20 0.42
▸ AEBP2 Q6ZN18 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18226799 0.87 DPP4 (0.51) HPGDDPP4RECQLEPHX1GPR119
SCHEMBL25924200 0.87 HPGD (0.49) HPGDDPP4RECQLEPHX1GPR119
SCHEMBL16225010 0.84 DPP4 (0.42) HPGDDPP4RECQLEPHX1GPR119
SCHEMBL19286080 0.84 GPR119 (0.54) HPGDDPP4RECQLEPHX1GPR119
SCHEMBL16212547 0.83 DPP4 (0.42) HPGDDPP4RECQLEPHX1GPR119
SCHEMBL25343622 0.83 HPGD (0.54) HPGDDPP4RECQLEPHX1GPR119
SCHEMBL6132431 0.82 HPGD (0.45) HPGDDPP4RECQLEPHX1GPR119
SCHEMBL1892198 0.81 HPGD (0.53) HPGDDPP4RECQLEPHX1GPR119
SCHEMBL31352385 0.81 HPGD (0.47) HPGDDPP4RECQLEPHX1GPR119
SCHEMBL5341723 0.80 HPGD (0.54) HPGDDPP4RECQLEPHX1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6040317-A AN ANTIAGGLOMERANTS USEFUL IN THE PREVENTION AND TREATMENT OF DISEASES CAUSED BY THROMBUS FORMATION MERCK & CO., INC. (US) 2000-03-21 — — US disclosed
EP-0743302-B1 Sulfonamide fibrinogen receptor antagonists MERCK & CO INC (US) 1999-08-04 — — EP disclosed
US-5880136-A PREVENTING THROMBUS FORMATION MERCK & CO., INC. (US) 1999-03-09 — — US disclosed
US-5814643-A ANTICOAGULANTS MERCK & CO., INC. (US) 1998-09-29 — — US disclosed
US-5658929-A ANTICOAGULANTS MERCK & CO., INC. (US) 1997-08-19 — — US disclosed
EP-0478363-B1 Novel sulfonamide fibrinogen receptor antagonists MERCK & CO INC (US) 1997-03-19 — — EP disclosed
EP-0743302-A2 Sulfonamide fibrinogen receptor antagonists MERCK & CO. INC. (US) 1996-11-20 — — EP disclosed
EP-0528587-B1 Inhibiting osteoclast-mediated bone resorption using substituted phenyl derivatives MERCK & CO INC (US) 1995-02-22 — — EP disclosed
US-5292756-A Novel sulfonamide fibrinogen receptor antagonists MERCK & CO., INC. (US) 1994-03-08 — — US disclosed
WO-1993019046-A1 NOVEL SULFONAMIDE FIBRINOGEN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1993-09-30 — — WO disclosed
US-5217994-A METHOD OF INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION BY ADMINISTRATION OF AMINOALKYL-SUBSTITUTED PHENYL DERIVATIVES MERCK & CO., INC. (US) 1993-06-08 — — US disclosed
US-5204350-A Treating osteoporosis MERCK & CO., INC. (US) 1993-04-20 — — US disclosed
EP-0528587-A1 Inhibiting osteoclast-mediated bone resorption using substituted phenyl derivatives MERCK & CO. INC. (US) 1993-02-24 — — EP disclosed
EP-0528586-A1 Inhibiting osteoclast-mediated bone resorption using aminoalkyl-substituted phenyl derivatives MERCK & CO. INC. (US) 1993-02-24 — — EP disclosed
EP-0478363-A2 Novel sulfonamide fibrinogen receptor antagonists MERCK & CO. INC. (US) 1992-04-01 — — EP disclosed
Send feedback